vimarsana.com
Home
Live Updates
Genomic Testing Is Worth the Wait When Balanced Against Cost
Genomic Testing Is Worth the Wait When Balanced Against Cost
Genomic Testing Is Worth the Wait When Balanced Against Cost of the Wrong Therapy
Coverage from the annual meeting, Patient-Centered Oncology Care®, presented by The American Journal of Managed Care® on November 7-8, 2023, in Nashville, Tennessee. This article will appear in the upcoming special issue of Evidence-Based Oncology™.
Related Keywords
Kentucky ,
United States ,
California ,
Tennessee ,
Puyallup ,
Washington ,
Californians ,
American ,
Sibel Blau ,
Bryan Loy ,
Davey Daniel ,
Joseph Alvarnas ,
American Cancer Society ,
Associated Press ,
National Cancer Care Alliance ,
Exigent Research ,
Quality Cancer Care Alliance ,
Health Equity ,
Northwest Medical Specialties ,
Centered Oncology Care ,
American Journal ,
Tennessee Oncology ,
Personalized Medicine ,
Medicare Advantage ,
California Medicaid ,
Cancer Genomics ,
Wall ,
Acute Lymphoblastic Leukemia ,
Pcoc ,
Precision Medicine ,
City Of Hope ,
Qcca ,
Humana ,
Oneoncology ,
Payers ,